DNA vaccine protection against SARS-CoV-2 in rhesus macaques

Prototype DNA vaccines for SARS-CoV-2 The development of a vaccine to protect against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an urgent biomedical need. Yu et al. designed a series of prototype DNA vaccines against the SARS-CoV-2 spike protein, which is used by the virus to bind and invade human cells. Analysis of the vaccine candidates in rhesus macaques showed that animals developed protective humoral and cellular immune responses when challenged with the virus. Neutralizing antibody titers were also observed at levels similar to those seen in humans who have recovered from SARS-CoV-2 infection. Science , this issue p. 806

• BW
  Burroughs Wellcome Fund
• BI
  Beth Israel Deaconess Medical Center
• RI
  Ragon Institute of MGH, MIT and Harvard
• MC
  Massachusetts Consortium on Pathogen Readiness
• NI
  National Institutes of Health

  Awards: AI124377, AI126603, AI007151, 272201700036I-0-759301900131-1, AI100625, AI110700, AI132178, AI149644, AI108197, AI139538, AI149644, AI110700, AI132178, AI100625, AI121394, AI129797, AI128751, OD024917, AI121394, AI139538, OD024917, AI129797, AI124377, AI128751, AI126603, AI146779, AI108197